{"id":149944,"date":"2022-11-11T15:25:48","date_gmt":"2022-11-11T21:25:48","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2022\/11\/new-antibiotic-achieves-success-in-clinical-trial"},"modified":"2022-11-11T15:25:48","modified_gmt":"2022-11-11T21:25:48","slug":"new-antibiotic-achieves-success-in-clinical-trial","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2022\/11\/new-antibiotic-achieves-success-in-clinical-trial","title":{"rendered":"New antibiotic achieves success in clinical trial"},"content":{"rendered":"<p style=\"padding-right: 20px\"><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/new-antibiotic-achieves-success-in-clinical-trial2.jpg\"><\/a><\/p>\n<p>If QPX9003 makes it through Phase II and III clinical trials and onto the market, it will be the first new lipopeptide antibiotic that targets Gram-negative bacteria in over 60 years.<\/p>\n<hr>\n<p>QPX9003, a new antibiotic for Gram-negative bacteria, has achieved success in a Phase I clinical trial.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>If QPX9003 makes it through Phase II and III clinical trials and onto the market, it will be the first new lipopeptide antibiotic that targets Gram-negative bacteria in over 60 years. QPX9003, a new antibiotic for Gram-negative bacteria, has achieved success in a Phase I clinical trial.<\/p>\n","protected":false},"author":566,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-149944","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/149944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/566"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=149944"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/149944\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=149944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=149944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=149944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}